News

This World Health Day, the International Society of Nephrology (ISN) invites the global community to spotlight the often-overlooked importance of kidney health as part of the broader conversation around public health and chronic disease prevention. Today is not only a time to reflect on ongoing health challenges but also to act in unison to protect […]

In March 2025, renowned renal pathologist and ISN Educational Ambassador (EA) Dr. Swarnalata Gowrishankar, from Apollo Hospitals in India, undertook a transformative two-week mission in Kigali, Rwanda. Her goal: to help establish and operationalize a renal pathology laboratory within the pathology department of Kigali University Teaching Hospital (CHUK), laying the groundwork for enhanced kidney disease

Kidney International Reports® (KIR) has recently published, as an article-in-press, insightful results from a comprehensive survey conducted by the ISN Western Europe Regional Board. The study explores the evolving preferences of nephrology professionals regarding scientific conference formats, evaluating in-person, virtual, and hybrid options in the context of post-pandemic realities. Titled “Nephrology Health Professionals’ Perspectives on

The International Society of Nephrology (ISN) continues to promote global collaboration and knowledge exchange by endorsing scientific and educational events that contribute meaningfully to kidney care advancement. In April 2025, ISN representatives will actively support two high-impact events: the 1st International Conference of Doctors and Students in Nephrology in Croatia, and the 2025 Congress of

Advancing Kidney Health Worldwide: Momentum Builds Ahead of WHA78 and Upcoming Global Milestones As 2025 unfolds with extraordinary opportunities to elevate kidney health on the global stage, I’m excited to share important developments that reflect the growing strength and scope of our advocacy initiatives. Together, we are shaping a more equitable and effective approach to

Navigating the complexities of rare kidney diseases can be daunting, even for seasoned healthcare professionals. To aid clinicians in meeting this challenge, the International Society of Nephrology (ISN) has developed a comprehensive Rare Kidney Diseases Toolkit. This expertly curated resource is designed to empower nephrologists and other care providers with practical tools to aid in

Kidney InternationalEconomic Evaluation of the CONVINCE Trial: High-Dose Online Hemodiafiltration vs. High-Flux Hemodialysis Chronic kidney disease patients undergoing dialysis often receive either high-flux hemodialysis (HD) or high-dose online hemodiafiltration (HDF). Emerging clinical evidence has indicated that HDF may offer a survival advantage over HD by reducing all-cause mortality. However, questions remain regarding the cost-effectiveness of

The International Society of Nephrology (ISN) strongly believes that people living with kidney disease must be at the heart of global kidney health efforts. As part of its unwavering commitment to patient-centered care, the ISN actively supports several initiatives that uplift and empower the patient voice, ensuring their experiences, needs, and insights are represented at

In a remarkable achievement for global pediatric nephrology, the 2025 Schrier Award was presented at WCN’25 to a thriving ISN Sister Renal Centers (SRC) partnership between the All India Institute of Medical Sciences (AIIMS), Bhopal, India, and the Montreal Children’s Hospital at McGill University Health Center, Canada. Representing the partnership, Dr. Girish Chandra Bhatt of

The International Society of Nephrology (ISN) is proud to introduce new chairs, deputy chairs, and members across its committees and working groups, with appointments effective from WCN’25. We extend our heartfelt thanks to outgoing leaders for their dedicated service and warmly welcome incoming members as they begin their new roles. ISN-ACT (Advancing Clinical Trials) Committee